|
Clinical Track
Sponsored by Smiths Medical
Monday, March 10
10:45 a.m. – 12:15 p.m.
 1-A. Infusion Therapy for the Older Adult—Vital Considerations!
ACPE # 207-999-08-159-L01-P
VNA Approver Number:
Pharmacy & Nursing Continuing Education Contact Hours: 1.5
Session Summary:
- Appreciate how, much like pediatric patients, older adults often require special attention to be successful on home I.V. therapy—especially as elderly patients may frequently have multiple chronic conditions and increased functional impairments that can interfere with (or make performing) basic tasks associated with self-administration more challenging.
- Consider why home infusion providers need to better prepare for addressing the needs of an older, more complex and growing generation of patients.
- Recognize the clinical and functional difficulties faced by elderly infusion patients—and listen to the experience of a home infusion provider that routinely serves a high percentage of older adults.
Faculty: Connie Maranville Sullivan, RPh, Infusion Director, Heartland IV Care, Lyons, CO
Educational Objectives:
- Describe the impact of an aging American population on medication utilization.
- Understand the pharmacokinetic changes and criteria for medication selection in the elderly.
- Describe the challenges facing elderly infusion patients.
- Evaluate infusion provider readiness for elderly home infusion patients
- Relate to one provider’s experience with serving the fragile and elderly.
4:15 – 5:45 p.m.
5-B. Successful Vascular Access Options for Pediatric Home Infusion
ACPE # 207-999-08-163-L01-P
VNA Approver Number:
Pharmacy & Nursing Continuing Education Contact Hours: 1.5
Session Summary:
- Review the history of vascular access device use in pediatric patients since the 1970s.
- Recognize how complications related to vascular access devices can be significantly reduced through appropriate device selection, careful ongoing assessment and effective education of the family caregiver.
- Study the most common complications of vascular access devices in children—and identify appropriate measures to prevent their occurrence.
Faculty: Baird Mallory, FACS, FAAP, FRCPS, MD, Maine Pediatric Surgical Associates, Portland, ME
Educational Objectives:
- Review the history of vascular access device development including key innovators and the catheters that they developed.
- Review vascular access catheter types and common complications associated with each type.
- List evidence-based best practices for catheter care for each type of access device.
- List considerations in vascular access device insertion and care specific to the pediatric population.
- List regulatory efforts and guidelines aimed at improving catheter outcomes.
Tuesday, March 11
10:45 a.m. – 12:15 p.m.
9-C. New Parenteral Drugs and Biologicals 2007: A Review for Home Care Practitioners
ACPE #207-999-08-169-L01-P
VNA Approver Number:
Pharmacy & Nursing Continuing Education Contact Hours: 1.5
Session Summary:
- Review how, since January of 2007, the FDA has approved a number of new pharmacological entities to treat acute and chronic conditions—specifically reflecting upon this content from the perspective of the home care clinician.
- Examine the new parenteral drugs and biologicals approved in 2007, their role in disease management and their clinical application in home care.
- Obtain a brief overview of select pipeline drugs.
Faculty: Anna Nowobilski-Vasilios, PharmD, MBA, FASHP, BCNSP, Chicago, IL
Educational Objectives:
- Highlight the pathophysiology and therapeutic goals for each corresponding disease state.
- Discuss the indications and appropriate role of each new agent.
- Describe the major adverse effects, contraindications, and precautions for each new agent.
- List issues relating to dosing, administration, storage, and program implementation for each new agent.
- Discuss patient education and monitoring interventions that would lead to achievement of therapeutic goals.
3:15 – 4:45 p.m.
13-D. Pharmacokinetics—Basic Principles and Practical Applications
ACPE # 207-999-08-173-L01-P
VNA Approver Number:
Pharmacy & Nursing Continuing Education Contact Hours: 1.5
Session Summary:
- Comprehend how “pharmacokinetics” attempts to accurately describe the time course of a drug as it is metabolized in the body.
- Receive an overview of the basic pharmacokinetic principles—and grasp the practical applications of these principles to the alternate-site infusion practice.
- Examine how the derivation, manipulation and study of related mathematical equations of varying degrees of sophistication have enabled clinicians to better understand the kinetics of absorption, distribution and elimination of medications.
Faculty: Pammi J. Farren, RPh, PhD, Branch Infusion Manager, Apria Healthcare, Columbus, OH
Educational Objectives:
- Describe basic principles of pharmacokinetics.
- Compare and contrast graphical and mathematical descriptions of pharmacokinetics.
- Discuss the impact of patient- and drug-specific factors on pharmacokinetic parameters.
- Describe how to apply pharmacokinetic principles to medications used in home infusion.
- List how to apply pharmacokinetic principles to aminoglycoside therapy.
5:00 – 6:30 p.m.
18-E. Specialty Infusion—Past, Present and Future!
ACPE #207-999-08-178-L04-P
VNA Approver Number:
Pharmacy & Nursing Continuing Education Contact Hours: 1.5
Session Summary:
- Understand a clear definition of the term “specialty infusion” and then compare it to what we think of as traditional home infusion, as well as specialty pharmacy.
- Engage in a thorough review of the economics of specialty infusion—including the costs of goods and services (COGS), labor, the impact of USP 797 and the effect of the NIOSH alert on facility requirements.
- Study risk-management considerations related to the high cost of handling and compounding specialty infusion drugs—inclusive of specialty drugs currently in the pipeline and service models that are suitable for each drug’s administration.
Faculty: Marc Stranz, PharmD, Healthcare Consultant, Evergreen, CO
Educational Objectives:
- Compare and contrast the term “specialty infusion” to traditional home infusion and specialty pharmacy.
- Discuss the financial considerations of providing specialty pharmacy infusion drugs and services.
- List risk-management considerations when compounding and handling specialty infusion drugs.
- Discuss the impact of the biotechnology pipeline and the use of various pharmacy distribution models on specialty infusion pharmacies.
- Describe several emerging business models for providing specialty infusion drug products and clinical services.
Interactive discussion and Q and A
Wednesday, March 12
9:15 – 10:15 p.m.
23-F. Ensuring Patient Safety through Medication Reconciliation
ACPE #207-999-08-182-L05-P
VNA Approver Number:
Pharmacy & Nursing Continuing Education Contact Hours: 1.0
Session Summary:
- Recognize how medication errors are among the most common medical errors, harming at least 1.5 million people every year—and grasp how accurate medication reconciliation across the healthcare continuum will eventually reduce medication errors/delays, while streamlining the admission, transfer and discharge processes from one care setting to another.
- Hear how the Joint Commission has made medication reconciliation a National Patient Safety Goal and review the campaigns that several other national patient safety organizations have initiated to standardize processes across all healthcare settings.
- Explore medication reconciliation process improvement approaches and focus on the critical steps required to meet accreditation standards—with particular attention paid to the role of home infusion pharmacies when collaborating with hospitals and home health agencies.
Faculty: Brian Swift, PharmD, MBA, Director, Health Ventures, Jefferson Health System, Philadelphia, PA
Educational Objectives:
- Discuss the implementation of a medication reconciliation process improvement initiative at your home infusion organization.
- Describe the use of Failure Mode and Effects Analysis (FMEA) in improving medication reconciliation processes.
Identify medication reconciliation best practices for home infusion providers.
- Describe the use of Failure Mode and Effects Analysis (FMEA) in improving medication reconciliation processes.
- Discuss the implementation of a medication reconciliation process improvement initiative at your home infusion organization.
10:30 a.m. – 12:00 p.m.
27-G. Patient Safety: Strategies for Preventing and Controlling Infections
ACPE #207-999-08-186-L05-P
VNA Approver Number:
Pharmacy & Nursing Continuing Education Contact Hours: 1.5
Session Summary:
- Explore how preventing and controlling infections is an integral component of an effective patient safety program in all care settings—and review key strategies for providing care and infusion therapy in the home, given the especially unique infection prevention and control challenges that arise in this setting.
- Understand the World Health Organization (WHO) and Centers for Disease Control and Prevention’s (CDC) hand hygiene guidelines, including how they are to be implemented in the home environment.
- Discuss approaches for reducing the risk of infection transmission associated with the use of medical equipment and supplies in the home—and what measures should be taken by home care staff to prevent the transmission of multi drug-resistant organisms (MDROs).
Faculty: Mary McGoldrick, MS, RN, CRNI® , Home Care and Hospice Consultant, Home Health Systems, Inc., Saint Simons Island, GA
Educational Objectives:
- Discuss the importance of infection prevention and control strategies as a patient safety initiative.
- Compare and contrast the World Health Organization’s (WHO) and the Centers for Disease Control and
- Prevention’s (CDC) hand hygiene guidelines.
- Describe strategies to reduce the risk of infection transmission associated with the use of medical equipment, devices and supplies used in the course of providing home care.
- Describe infection prevention and control issues specific to patients with multi drug-resistant organisms (MDROs) receiving care in the home.
- Identify methods to strengthen the infection prevention and control practices in the home care setting.
1:30 – 2:30 p.m.
31-H. Diabetic Foot Infections: New Classification Tools
ACPE #207-999-08-191-L01-P
VNA Approver Number:
Pharmacy & Nursing Continuing Education Contact Hours: 1.0
Session Summary:
- Consider how patients with diabetic foot infections are frequently treated with intravenous antibiotics in the alternate-care setting—and review the Diabetic Foot Infection Guidelines published by the Infectious Diseases Society of America.
- Examine how these evidence-based consensus guidelines describe whether or not a diabetic foot ulceration is infected—and if infected, the severity of the infection, the organisms causing the infection and antibiotics needed to treat those organisms.
- Focus on how best to address the significant role of resistant organisms in these cases.
Faculty: Warren Joseph, DPM, FIDSA, VA Medical Center, Coatesville, PA
Educational Objectives:
- Discuss the pathophysiology for ulceration and infection of the diabetic foot.
- Differentiate the severity of diabetic foot infections based on criteria from the IDSA.
- Understand the Infectious Diseases Society of America Diabetic Foot Infection Guidelines.
- Define the role the MRSA plays in the diabetic foot infection.
- Determine appropriate antibiotic therapy for the treatment of the varying severities of diabetic foot infections.
2:45 – 4:15 p.m.
 35-I. Ensuring Clinical Documentation Meets the Needs of Your Reimbursement Team
ACPE #207-999-08-195-L04-P
VNA Approver Number:
Pharmacy & Nursing Continuing Education Contact Hours: 1.5
Session Summary:
- Review the everyday communication challenges that frequently exist between clinicians and the reimbursement team.
- Identify what the clinical staff knows about their patients that the reimbursement team needs to know in order to bill on a timely, accurate basis—and realize the benefits of a defined communication process to achieve this goal.
- Assess clinical documentation/communications from the clinical team to the reimbursement staff—and examine alternate communication methods to help further ensure success.
Faculty: Cindy Gricheck, RN, BSN, CRNI® , Manager, Infusion Operations, Air Products Healthcare, Monroeville, PA, and Vicki Wilson, Senior Manager/Consultant, Reimbursement Concepts, Weirton, WV
Educational Objectives:
- List challenges to overcome when communicating pertinent information.
- Define what information needs to be communicated and to whom from the clinical staff to the reimbursement staff and vice-versa.
- Define the elements of successful communications.
- Identify various forms of communication.
- Describe benefits of communication from the clinical personnel to reimbursement department.
|
